Condition: Non-small Cell Lung Cancer · Sponsor: Daiichi Sankyo
This clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with pembrolizumab in participants with no prior therapy for locally advanced unresectable or metastatic non-squamous NSCLC, whose tumors have HER2-overexpressing and PD-L1 TPS \<50% without known AGA that have locally available therapies targeting their AGAs in first-line advanced/metastatic setting.
This description comes directly from the study's public registry record.
Contact for Trial Information · 908-992-6400 · CTRinfo_us@daiichisankyo.com
Always discuss trial participation with your own doctor first.
| Alaska Oncology & Hematology, LLC | Anchorage, Alaska, United States | Recruiting |
| Orange Coast Memorial Medical Center Fountain Valley | Fountain Valley, California, United States | Recruiting |
| California Research Institute | Los Angeles, California, United States | Recruiting |
| Los Angeles Cancer Network (LACN) | Los Angeles, California, United States | Recruiting |
| Providence Medical Foundation | Santa Rosa, California, United States | Recruiting |
| Bay Pines VA Healthcare System | Bay Pines, Florida, United States | Recruiting |
| Lynn Cancer Institute Center | Boca Raton, Florida, United States | Recruiting |
| Holy Cross Hospital | Fort Lauderdale, Florida, United States | Recruiting |
| Mid-Florida Hematology & Oncology Centers, P.A. | Orange City, Florida, United States | Recruiting |
| BRCR Global Plantation | Plantation, Florida, United States | Recruiting |
| Cleveland Clinic Florida - Weston | Weston, Florida, United States | Recruiting |
| Piedmont Cancer Institute OneOncology | Atlanta, Georgia, United States | Recruiting |
+ 225 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06899126